{"pmid":32417164,"title":"Treatment of sleep apnea by ENT specialists during the COVID-19 pandemic.","text":["Treatment of sleep apnea by ENT specialists during the COVID-19 pandemic.","The treatment of sleep disorders has been strongly impacted by the COVID-19 pandemic. When the lockdown is over, resumption of usual patient care will require precautions to limit the risk of contamination for patients and caregivers. In this document, the French Association of Otorhinolaryngology and Sleep disorders (AFSORL) and the French Society of Otorhinolaryngology (SFORL) put forward a summary of the measures for continuing the treatment of sleep apnoea syndrome in these new practice conditions. Emphasis is placed on teleconsultation, methods of nocturnal sleep studies, the conditions for treatment by continuous positive airway pressure (CPAP) ventilation, and the postponement of more invasive treatments.","Eur Ann Otorhinolaryngol Head Neck Dis","Bastier, P-L","Aisenberg, N","Durand, F","Lestang, P","Abedipour, D","Gallet de Santerre, O","Couloigner, V","Bequignon, E","32417164"],"abstract":["The treatment of sleep disorders has been strongly impacted by the COVID-19 pandemic. When the lockdown is over, resumption of usual patient care will require precautions to limit the risk of contamination for patients and caregivers. In this document, the French Association of Otorhinolaryngology and Sleep disorders (AFSORL) and the French Society of Otorhinolaryngology (SFORL) put forward a summary of the measures for continuing the treatment of sleep apnoea syndrome in these new practice conditions. Emphasis is placed on teleconsultation, methods of nocturnal sleep studies, the conditions for treatment by continuous positive airway pressure (CPAP) ventilation, and the postponement of more invasive treatments."],"journal":"Eur Ann Otorhinolaryngol Head Neck Dis","authors":["Bastier, P-L","Aisenberg, N","Durand, F","Lestang, P","Abedipour, D","Gallet de Santerre, O","Couloigner, V","Bequignon, E"],"date":"2020-05-18T11:00:00Z","year":2020,"_id":"32417164","source":"PubMed","week":"202021|May 18 - May 24","doi":"10.1016/j.anorl.2020.05.001","keywords":["covid-19","cpap (continuous positive airway pressure)","coronavirus","hygiene","mandibular advancement device (mad)","osas (obstructive sleep apnea syndrome)","organisation of treatment","otorhinolaryngology","polygraph","sars-cov-2","sleep apnoea","sleep disorders","sleep endoscopy"],"topics":["Prevention"],"weight":1,"_version_":1667058206843600897,"score":9.490897,"similar":[{"pmid":32295323,"title":"[Expert consensus on sleep study and non-invasive positive airway pressure therapy during the epidemic of coronavirus disease 2019].","text":["[Expert consensus on sleep study and non-invasive positive airway pressure therapy during the epidemic of coronavirus disease 2019].","Coronavirus disease 2019 (COVID-19) is mainly transmitted through respiratory droplets, close unprotected contact, and intense aerosols-generating procedures. Sleep study and non-invasive positive airway pressure (NIPAP) therapy can increase the risk of exposure and transmission of new coronaviruses to medical staff and patients. China's national epidemic control has entered a critical stage of overall prevention and control together with the restoration of normal medical care delivery. Based on the characteristics of sleep-disordered breathing, this consensus elaborates on the recommendations from the following four aspects that include patient and medical staff education, optimization of diagnostic and treatment protocols, sterilization of medical devices and the environment, and control of hospital-acquired infection. It is emphasized that the indications for sleep study and NIPAP should be strictly defined according to the local epidemic situation. Portable home sleep study and auto-titration positive airway pressure is recommended. The applications of disposable nasal pressure transducer for sleep study and disposable or personal masks and ventilator tubing for NIPAP are strongly suggested. Moreover, it is necessary to standardize the procedure of NIPAP, to separate the functional divisions in sleep lab, to comply with the protection regulations for medical personnel, and to strengthen the cleaning and disinfection management.","Zhonghua Jie He He Hu Xi Za Zhi","32295323"],"abstract":["Coronavirus disease 2019 (COVID-19) is mainly transmitted through respiratory droplets, close unprotected contact, and intense aerosols-generating procedures. Sleep study and non-invasive positive airway pressure (NIPAP) therapy can increase the risk of exposure and transmission of new coronaviruses to medical staff and patients. China's national epidemic control has entered a critical stage of overall prevention and control together with the restoration of normal medical care delivery. Based on the characteristics of sleep-disordered breathing, this consensus elaborates on the recommendations from the following four aspects that include patient and medical staff education, optimization of diagnostic and treatment protocols, sterilization of medical devices and the environment, and control of hospital-acquired infection. It is emphasized that the indications for sleep study and NIPAP should be strictly defined according to the local epidemic situation. Portable home sleep study and auto-titration positive airway pressure is recommended. The applications of disposable nasal pressure transducer for sleep study and disposable or personal masks and ventilator tubing for NIPAP are strongly suggested. Moreover, it is necessary to standardize the procedure of NIPAP, to separate the functional divisions in sleep lab, to comply with the protection regulations for medical personnel, and to strengthen the cleaning and disinfection management."],"journal":"Zhonghua Jie He He Hu Xi Za Zhi","date":"2020-04-17T11:00:00Z","year":2020,"_id":"32295323","source":"PubMed","week":"202016|Apr 13 - Apr 19","doi":"10.3760/cma.j.cn112147-20200309-00283","keywords":["covid-19","infection prevention and protection","non-invasive positive airway pressure","sleep study"],"locations":["China"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Prevention"],"weight":1,"_version_":1666138493234970624,"score":255.84279},{"pmid":32312676,"pmcid":"PMC7165275","title":"COVID-19 and ENT Pediatric otolaryngology during the COVID-19 pandemic. Guidelines of the French Association of Pediatric Otorhinolaryngology (AFOP) and French Society of Otorhinolaryngology (SFORL).","text":["COVID-19 and ENT Pediatric otolaryngology during the COVID-19 pandemic. Guidelines of the French Association of Pediatric Otorhinolaryngology (AFOP) and French Society of Otorhinolaryngology (SFORL).","OBJECTIVE: Joint guidelines of the French Pediatric Otolaryngology Society (AFOP) and of the French Society of otorhinolaryngology-head and neck surgery (SFORL) on the management of paediatric otolaryngology patients in the context of the COVID-19 pandemic. METHODS: A nation-wide workgroup drew guidelines based on clinical experience, national and local recommendations and scientific literature. Proposals may have to be updated on a day-to-day basis. RESULTS: In children, incidence of symptomatic COVID-19 (1-5%) is low and of good prognosis. The indications for nasal flexible endoscopy should be drastically limited. If undertaken, full Personal Protective Equipment (PPE) including FFP2 masks are required, as well as use of a sheath. Saline nose wash done by caregivers other than parents at home should require PPE. Unless foreign body tracheobronchial aspiration is clinically obvious, CT-scan should be performed to confirm indication of endoscopy. Surgical indications should be limited to emergencies and to cases that cannot be delayed beyond 2 months (especially endonasal, endopharyngeal laryngo-tracheobronchial procedures). Postponement should ideally be a group decision and recorded as such in the medical file. Surgical techniques should be adapted to limit the risk of viral dissemination in the air, avoiding the use of drills, microdebriders, monopolar cautery or lasers. Continuous suction should be placed near the operating field. In case of confirmed Covid-19 cases, or suspected cases (or in some centres systematically), PPE with FFP2 mask should be worn by all staff members present in the operating room.","Eur Ann Otorhinolaryngol Head Neck Dis","Leboulanger, N","Sagardoy, T","Akkari, M","Ayari-Khalfallah, S","Celerier, C","Fayoux, P","Luscan, R","Mansbach, A-L","Moreddu, E","Pondaven, S","Simon, F","Teissier, N","Thierry, B","Fanous, A","Lescanne, E","Nicollas, R","Couloigner, V","32312676"],"abstract":["OBJECTIVE: Joint guidelines of the French Pediatric Otolaryngology Society (AFOP) and of the French Society of otorhinolaryngology-head and neck surgery (SFORL) on the management of paediatric otolaryngology patients in the context of the COVID-19 pandemic. METHODS: A nation-wide workgroup drew guidelines based on clinical experience, national and local recommendations and scientific literature. Proposals may have to be updated on a day-to-day basis. RESULTS: In children, incidence of symptomatic COVID-19 (1-5%) is low and of good prognosis. The indications for nasal flexible endoscopy should be drastically limited. If undertaken, full Personal Protective Equipment (PPE) including FFP2 masks are required, as well as use of a sheath. Saline nose wash done by caregivers other than parents at home should require PPE. Unless foreign body tracheobronchial aspiration is clinically obvious, CT-scan should be performed to confirm indication of endoscopy. Surgical indications should be limited to emergencies and to cases that cannot be delayed beyond 2 months (especially endonasal, endopharyngeal laryngo-tracheobronchial procedures). Postponement should ideally be a group decision and recorded as such in the medical file. Surgical techniques should be adapted to limit the risk of viral dissemination in the air, avoiding the use of drills, microdebriders, monopolar cautery or lasers. Continuous suction should be placed near the operating field. In case of confirmed Covid-19 cases, or suspected cases (or in some centres systematically), PPE with FFP2 mask should be worn by all staff members present in the operating room."],"journal":"Eur Ann Otorhinolaryngol Head Neck Dis","authors":["Leboulanger, N","Sagardoy, T","Akkari, M","Ayari-Khalfallah, S","Celerier, C","Fayoux, P","Luscan, R","Mansbach, A-L","Moreddu, E","Pondaven, S","Simon, F","Teissier, N","Thierry, B","Fanous, A","Lescanne, E","Nicollas, R","Couloigner, V"],"date":"2020-04-22T11:00:00Z","year":2020,"_id":"32312676","source":"PubMed","week":"202017|Apr 20 - Apr 26","doi":"10.1016/j.anorl.2020.04.010","keywords":["covid-19","coronavirus","ent","otolaryngology","paediatric","pandemic","sars-cov-2"],"locations":["French"],"countries":["France"],"countries_codes":["FRA|France"],"topics":["Prevention"],"weight":1,"_version_":1666138493560029184,"score":245.67363},{"pmid":32482571,"title":"Consensus statement. Corticosteroid therapy in ENT in the context of the COVID-19 pandemic.","text":["Consensus statement. Corticosteroid therapy in ENT in the context of the COVID-19 pandemic.","This consensus statement about the indications and modalities of corticosteroid treatment in the context of the COVID-19 pandemic was jointly written by experts from the French Association of Otology and Oto-Neurology (AFON) and from the French Society of Otorhinolaryngology, Head and Neck Surgery (SFORL). There is currently not enough data in favour of danger or benefit from corticosteroids in COVID-19, so until this matter is resolved it is advisable to limit their indications to the most serious clinical pictures for which it is well established that this type of treatment has a positive impact on the progression of symptoms. In Grade V and VI Bell's palsy according to the House-Brackmann grading system, a week's course of oral corticosteroids is recommended. Corticosteroid therapy is also recommended in cases of sudden hearing loss of more than 60dB, either in the form of intratympanic injections or a week's course of oral medication. In rhinology, there is no indication for systemic corticosteroid therapy in the current situation. However, patients are advised to continue with their local corticosteroid therapy in the form of a nasal spray or by inhalation. Treatments with corticosteroid nasal sprays can still be prescribed if there is no alternative. Finally, systemic or local corticosteroid therapy is not indicated for bacterial ENT infections.","Eur Ann Otorhinolaryngol Head Neck Dis","Herman, P","Vincent, C","Parietti Winkler, C","Loundon, N","Couloigner, V","Tankere, F","Tringali, S","Gallet, P","Papon, J-F","Montava, M","Lavieille, J-P","Charpiot, A","Schmerber, S","32482571"],"abstract":["This consensus statement about the indications and modalities of corticosteroid treatment in the context of the COVID-19 pandemic was jointly written by experts from the French Association of Otology and Oto-Neurology (AFON) and from the French Society of Otorhinolaryngology, Head and Neck Surgery (SFORL). There is currently not enough data in favour of danger or benefit from corticosteroids in COVID-19, so until this matter is resolved it is advisable to limit their indications to the most serious clinical pictures for which it is well established that this type of treatment has a positive impact on the progression of symptoms. In Grade V and VI Bell's palsy according to the House-Brackmann grading system, a week's course of oral corticosteroids is recommended. Corticosteroid therapy is also recommended in cases of sudden hearing loss of more than 60dB, either in the form of intratympanic injections or a week's course of oral medication. In rhinology, there is no indication for systemic corticosteroid therapy in the current situation. However, patients are advised to continue with their local corticosteroid therapy in the form of a nasal spray or by inhalation. Treatments with corticosteroid nasal sprays can still be prescribed if there is no alternative. Finally, systemic or local corticosteroid therapy is not indicated for bacterial ENT infections."],"journal":"Eur Ann Otorhinolaryngol Head Neck Dis","authors":["Herman, P","Vincent, C","Parietti Winkler, C","Loundon, N","Couloigner, V","Tankere, F","Tringali, S","Gallet, P","Papon, J-F","Montava, M","Lavieille, J-P","Charpiot, A","Schmerber, S"],"date":"2020-06-03T11:00:00Z","year":2020,"_id":"32482571","source":"PubMed","week":"202023|Jun 01 - Jun 07","doi":"10.1016/j.anorl.2020.04.014","keywords":["anosmia","bell's palsy","covid-19","prednisone","sars-cov-2","sudden hearing loss"],"topics":["Prevention"],"weight":1,"_version_":1668532114875744257,"score":244.44185},{"pmid":32472773,"title":"A COVID-19 Conundrum: Obstructive Sleep Apnea (OSA) and Non-Invasive Ventilation (NIV).","text":["A COVID-19 Conundrum: Obstructive Sleep Apnea (OSA) and Non-Invasive Ventilation (NIV).","The challenges imposed by the COVID-19 pandemic become amplified in the setting of non-intubated patients with obstructive sleep apnea. Unlike the closed system that characterizes an intubated patient attached to a respiratory circuit, non-invasive ventilatory support threatens an increased risk of permeating the clinical workspace with airborne viral particles. Patients with sleep apnea may mandatorily require non-invasive ventilation strategies to see them through a respiratory illness. In this infographic, the considerations and general principles of managing non-invasive ventilation in such a scenario are outlined. The reader is encouraged to review the article in its entirety for a full depth of understanding.","Anesth Analg","32472773"],"abstract":["The challenges imposed by the COVID-19 pandemic become amplified in the setting of non-intubated patients with obstructive sleep apnea. Unlike the closed system that characterizes an intubated patient attached to a respiratory circuit, non-invasive ventilatory support threatens an increased risk of permeating the clinical workspace with airborne viral particles. Patients with sleep apnea may mandatorily require non-invasive ventilation strategies to see them through a respiratory illness. In this infographic, the considerations and general principles of managing non-invasive ventilation in such a scenario are outlined. The reader is encouraged to review the article in its entirety for a full depth of understanding."],"journal":"Anesth Analg","date":"2020-05-31T11:00:00Z","year":2020,"_id":"32472773","source":"PubMed","week":"202022|May 25 - May 31","doi":"10.1213/ANE.0000000000004998","topics":["Prevention"],"weight":1,"_version_":1668255193451462656,"score":212.25735},{"pmid":32474941,"title":"Editorial Perspective: Perils and promise for child and adolescent sleep and associated psychopathology during the COVID-19 pandemic.","text":["Editorial Perspective: Perils and promise for child and adolescent sleep and associated psychopathology during the COVID-19 pandemic.","It is anticipated that the novel coronavirus disease 2019 (COVID-19) pandemic and associated societal response will have wide-ranging impacts on youth development and mental health. Sleep is crucial for child and adolescent health and well-being, and the potential for sleep problems to emerge or worsen during and following the pandemic is high. This may be particularly true for children and adolescents who are at heightened risk for the onset of sleep and mental health disturbances and for those whom developmental changes impacting sleep are rapidly occurring. Youth with preexisting psychopathologies (including anxiety and depression) and neurodevelopmental conditions (including attention-deficit/hyperactivity disorder and autism spectrum disorder) could be especially vulnerable to disturbed sleep during this period of change and uncertainty. It is thus imperative that sleep considerations be part of research and clinical initiatives aimed at understanding and mitigating the impact of the COVID-19 pandemic in children and adolescents. This article considers ways in which the pandemic may impact sleep, including research and clinical implications.","J Child Psychol Psychiatry","Becker, Stephen P","Gregory, Alice M","32474941"],"abstract":["It is anticipated that the novel coronavirus disease 2019 (COVID-19) pandemic and associated societal response will have wide-ranging impacts on youth development and mental health. Sleep is crucial for child and adolescent health and well-being, and the potential for sleep problems to emerge or worsen during and following the pandemic is high. This may be particularly true for children and adolescents who are at heightened risk for the onset of sleep and mental health disturbances and for those whom developmental changes impacting sleep are rapidly occurring. Youth with preexisting psychopathologies (including anxiety and depression) and neurodevelopmental conditions (including attention-deficit/hyperactivity disorder and autism spectrum disorder) could be especially vulnerable to disturbed sleep during this period of change and uncertainty. It is thus imperative that sleep considerations be part of research and clinical initiatives aimed at understanding and mitigating the impact of the COVID-19 pandemic in children and adolescents. This article considers ways in which the pandemic may impact sleep, including research and clinical implications."],"journal":"J Child Psychol Psychiatry","authors":["Becker, Stephen P","Gregory, Alice M"],"date":"2020-06-01T11:00:00Z","year":2020,"_id":"32474941","source":"PubMed","week":"202023|Jun 01 - Jun 07","doi":"10.1111/jcpp.13278","weight":0,"_version_":1668341932682641408,"score":211.17616}]}